Abstract
Lactic acid bacteria (LAB) have been used in a wide variety of industrial fermentation processes. Generally, LAB have regarded as safe status, making them potentially useful organisms for the production of commercially important proteins. Here, we developed protein expression systems using Lactococcus lactis MG1363 for which the protein of interest is targeted to a defined cell location, e.g., cytoplasm, cell wall, and medium. The expression system of human granulocyte-macrophage colony-stimulating factor (hGM-CSF) was successfully constructed, and the expression of hGM-CSF in the cytoplasm of L. lactis was detected by Western blotting. Efficient translocation was obtained using the signal peptide from lactococcal Usp45 protein and covalently anchored to the peptidoglycan by using the cell wall anchor motif of Streptococcus pyogenes M6 protein. These results suggest that L. lactis containing a new expression system can deliver many other useful genes to the intestine of human and mammalian to stimulate local mucosal immunity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Caplice E, Fitzgerald GF. Food fermentations: Role of microorganisms in food production and preservation. Int. J. Food Microbiol. 50: 131–149 (1999)
Marteau P, Rambaud JC. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol. Rev. 12: 207–220 (1993)
Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M, Rowland I. Functional food science and gastrointestinal physiology and function. Brit. J. Nutr. 80: S147–S171 (1998)
Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM. Mucosal immunity: implications for vaccine development. Immunobiology 184: 157–179 (1992)
Steidler L, Robinson K, Chamberlain L, Schofield KM, Remaut E, Le Page RW, Wells JM. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect. Immun. 66: 3183–3189 (1998)
Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289: 1352–1355 (2000)
Bermúdez-Humarán LG, Langella P, Cortes-Perez NG, Gruss A, Tamez-Guerra RS, Oliveira SC, Saucedo-Cardenas O, Montes de Oca-Luna R, Le Loir Y. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect. Immun. 71: 1887–1896 (2003)
Pontes DS, de Azevedo MS, Chatel JM, Langella P, Azevedo V, Miyoshi A. Lactococcus lactis as a live vector: Heterologous protein production and DNA delivery systems. Protein Expres. Purif. 79: 165–175 (2011).
Francisco-Cruz A, Aguilar-Santelises M, Ramos-Espinosa O, Mata-Espinosa D, Marquina-Castillo B, Barrios-Payan J, Hernandez-Pando R. Granulocytemacrophage colony-stimulating factor: Not just another haematopoietic growth factor. Med. Oncol. 31: 774 (2014)
Hansen PJ, Dobbs KB, Denicol AC. Programming of the preimplantation embryo by the embryokine colony stimulating factor 2. Anim. Reprod. Sci. 149: 59–66 (2014)
Dieye Y, Hoekman AJ, Clier F, Juillard V, Boot HJ, Piard JC. Ability of Lactococcus lactis to export viral capsid antigens: A crucial step for development of live vaccines. Appl. Environ. Microb. 69: 7281–7288 (2003)
Borrero J, Jiménez JJ, Gútiez L, Herranz C, Cintas LM, Hernández PE. Use of the usp45 lactococcal secretion signal sequence to drive the secretion and functional expression of enterococcal bacteriocins in Lactococcus lactis. Appl. Microbiol. Biot. 89: 131–143 (2011)
Piard JC, Hautefort I, Fischetti VA, Ehrlich SD, Fons M, Gruss A. Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria. J. Bacteriol. 179: 3068–3072 (1997)
Henrich B, Klein JR, Weber B, Delorme C, Renault P, Wegmann U. Food-grade delivery system for controlled gene expression in Lactococcus lactis. Appl. Environ. Microb. 68: 5429–5436 (2002)
Platteeuw C, van Alen-Boerrigter I, van Schalkwijk S, de Vos WM. Food-grade cloning and expression system for Lactococcus lactis. Appl. Environ. Microb. 62: 1008–1013 (1996)
Dickely, F, Nilsson D, Hansen EB, Johansen E. Isolation of Lactococcus lactis nonsense suppressors and construction of a food-grade cloning vector. Mol. Microbiol. 15: 839–847 (1995)
Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP, Steidler L. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin. Gastroenterol. H. 4: 754–759 (2006)
Rottiers P, De Smedt T, Steidler L. Modulation of gut-associated lymphoid tissue functions with genetically modified Lactococcus lactis. Int. Rev. Immunol. 28: 465–486 (2009)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hong, YF., Ham, M.S., Park, W.J. et al. Construction of human granulocyte-macrophage colonystimulating factor expression system using Lactococcus lactis MG1363. Food Sci Biotechnol 24, 2145–2149 (2015). https://doi.org/10.1007/s10068-015-0285-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10068-015-0285-7